SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
58 hedge funds and large institutions have $49.7M invested in Strongbridge Biopharma plc. in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
24
Reduced
10
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.07M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.25M |
| 3 |
Renaissance Technologies
New York
|
+$909K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$903K |
| 5 |
DT
Diversified Trust
Memphis,
Tennessee
|
+$415K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$6.16M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$2.63M |
| 3 |
2L
22NW LP
Seattle,
Washington
|
-$1.92M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.17M |
| 5 |
BlackRock
New York
|
-$1.11M |
